Marketing, Sales, Launch Excellence, HCP/Patient Communications

Andrew H. Isaacs

**********@*****.*** (Cell) 908-***-****

** ******* ***** *****, **********, NJ 07921

Professional Profile

Highly Accomplished Multi-Functional Leader Within Top Tier Pharmaceutical, Medical Device, Consulting, and Technology Integration Industries with Successful Accomplishments in the following areas Marketing & Launch Excellence VP Commercial Operations VP Marketing/Strategy/Business Dev. End-End Content/Channel Optimization Global Resource Optimization Portfolio Strategy/Vision Roadmap

>$1B Global/US Brand Budget Mgt Vendor/Partner/Demand Management Cross Functional Transformation NPD & Licensing Assessments Market Research, Insights, KPIs, Analytics MLR/FDA Compliance/Risk Mitigation Senior Level Experience Driving Organizational Transformation with Value Based Insights BioMedical and MBA/MS Graduate Degrees Coupled with Extensive Senior Professional Leadership Expertise Resulting in Significant Improvements in Portfolio Planning, Go-To-Market Strategies, Operational Efficiencies, Technology Optimization, HCP/Patient Services, Clinical Guidelines, Demand Management, Procurement, and Transforming Operational Excellence into a Competitive Advantage. Passionate Leader with 50+ LinkedIn Recommendations, Multiple Thought Leadership Publications, Industry Conference Presenter, University Lecturer, Founder of Non-Profit on Childhood Diseases, Outstanding Operations Awards, Community Services Award. Professional Experience

Aug 2024 - Present INTERSTICE THERAPEUTICS - Biotech President

§ Founded Interstice Therapeutics, LLC, a biotech company focused on rapid development and approval of novel 505b(2) drugs to address anticipated and/or real world branded New Drug Application (NDA) treatment adoption gaps

§ Lead drug assessments, manage KOL advisory board, and interact with FDA

§ Lead the creation and oversee the submission of United States Patent & Trade Office (USPTO) submissions

§ Develop pre-commercialization strategies, create go-to-market financial models, and create investor presentations Jan 2020 – Aug 2024 NOVARTIS - Global Pharmaceutical Company Vice President, Marketing Operations (~100+ US/Global staff)

§ Lead organizational design, ROI, deliverables, role descriptions, and operationalization of newly centralized Operations competency for combined US ONCO/Pharma businesses that supports >4,000 Stakeholders with $2B in spend

§ Oversight for all US Integrated Marketing Business Policies/Practices, Digital/Above Brand Governance Boards, Content Supply Chain, Modular Assets, Med Ed, Holding Company/Agency/Media Mgt, Supplier Mgt, Demand Mgt, Training, and Promo/Medical Review

§ Mar-Tach Strategic Objectives Planning & Prioritization, Aprimo, Veeva, SFMC, Screen Dragon, Tealium, QLIK, ObservePoint, AI

§ Establish First Centralized Demand Management Process, Policies, Platform that resulted in ~$50mn in spend optimization each year

§ Established First Centralized Promotional Tactic Catalogue 8 segments with~700 individual Tactics Driving Significant Efficiencies

§ Centralized and Operationalized Multiple New Brand Planning, Financial, and Supplier Relationships Business and Planning Processes

§ Created First Journey Based Learning HUB

§ Reduced Content Time/Effort for Asset Throughput by 40% With Increase in Volume by 80% and Outperformed Industry Benchmark

§ P/L Oversight >$1B and established new ways of working with strategic/vendor partners which exceeded 1 year savings

§ Recipient of 2024 Business Excellence Award and sought After Coach/Mentor, Industry Conference Speaker, College Guest Lecturer Head of Marketing Operations US Pharma (70+ staff)

§ Lead Content Supply Chain initiative encompassing operationalizing a ten-step gating process for ~2,000 asset creation, approval, and digital asset management stakeholders, digital asset design/development criteria, upstream-downstream system content and metadata matrices, Agencies of Record, asset operational/utilization/message effectiveness metrics

§ Lead US requirements as Triad member on Global Leadership teams for all Content Supply Chain & Marketing Operations initiatives; asset management, customer data platforms, review/approvals, and operations transformation

§ Co-lead Next Generation Engagement organizational transformation to Digital Content Personalization with Decision Engine Orchestration

§ Led assessment, benchmarking, mission/vision, and Operations organizational structure recommendations for core competencies align with transformational journey

§ Led multiple operational transformations resulted in 30% operational efficiencies, $$MM cost savings, 40% speed to market improvement Chief of Staff & Head of Strategic Planning and Effectiveness Member Commercial Operations Team (200+ staff)

§ Led transformational activities for Ways of Working, Planning and Effectiveness, and Business Value for New Organizational Capability Consisting of Advanced Analytics, Business Insights, Call Center, Data/Platforms/Reporting, Operations, Market Research, & Training

§ Revised Vision/Purpose, Established CA Culture Mindset, Developed Up-Skilling Competency Training, and Structured Operating Rhythm

§ Led 2020 Strategic Objectives Planning & Prioritization, Leadership Team Collaboration, and Executive Team Presentations

§ Led Multiple Key Strategic Initiatives; Omni-Channel Marketing, Metrics that Matter, & Marketing Operations, encompassing Business Rational, Workstreams, Resource Requirements, and Budgets

§ Facilitated Best Practices Knowledge Sharing with Academia, Global Pharma, External Service Providers, and Technology Partners 2011-12, 2014 – Jan 2020 COGNIZANT - Global Consulting Organization Global Principal, Life Sciences Business Unit Lead Global Marketing & Operations Transformational Initiatives (50-100 staff)

§ Analytics, Artificial Intelligence, Digital Transformation, Marketing Tech, Medical, Natural Language Processing

§ Developed Integrated Marketing Excellence Solutions and Comprehensive Strategies for Commercial Operations, New Product Development, Business Strategy, Portfolio Planning, Demand Mgt, Digital Content Ecosystems, Global Compliance, Digital Analytics and Tag Management, Real Time Marketing, Promotional Review/Approval, Digital Analytics, Marketing Automation Platforms, Digital Asset Management, Artificial Intelligence, Multi-Channel Management, and Technology Assessments

§ Led Optimization and Transformational Consulting Services to Global Bio-Pharma Organizations Across Marketing, Commercial Operations, Artificial Intelligence, Brand Launch, Data Analytics/Visualization, Compliance, Content and Analytic Tag Mgt, Change Mgt

§ Led New Product Development Assessments for Multiple In-Licensing Compounds

§ Led New Service Development and Published Multiple White Papers (i.e.: Virtual Brand Management)

§ Oversaw Cross-Functional Service Delivery Teams on Engagements Spanning $100K - $20MM

§ Global Alliance Manager for external technology providers (i.e.: ObservePoint, Tealium, ZINC)

§ Recipient of the Cognizant Innovation Award for New Service Offerings 2012 - 2013 BRISTON MYERS SQUIBB - Global Pharmaceutical Head, COMMERCIAL PROCESS and PRACTICES LEAD, Bristol Myers Squibb Functional Leader for US and Global Commercial Operations Transformational Initiatives

§ Led Optimization and Transformation Activities for Global Commercial Processes Including Marketing Processes, Global Brand Planning, Product Commercialization Planning, Demand and Vendor Mgt, and US Promotional Material Development & Approval

§ Acted as Commercial Strategy Subject Matter Expert, Develop Optimization Work-Streams, Oversee Cross-Functional Stakeholder Teams, Lead Executive Level Governance Team, and Restructure/Consolidate Operational Resources

§ Leveraged Six-Sigma Business Planning Processes Assessment Methodologies and Work-Stream Improvement Principles, Along with Oversight and Execution of all Relevant Business Processes Across all Internal HUBs (Centers of Excellence)

§ Individual and Team Recognition, including BMS “Distinction Award” for Cross-Functional Team Excellence in Process Optimization 2010 - 2011 Medical Communications Organization

Chief Strategy Officer, Medical Communications, Phoenix Marketing Solutions Responsible for Restructuring Company Offerings and Go To Market Services (90+ staff)

§ Led Organizational Value Positioning & Solution Monetization

§ Led New Services Generation Throughout Lifecycle Development Phases, Across Multiple Therapeutic Areas, Competitive Landscape Analysis, HEOR Value Propositions, Optimizing Tactical Planning Initiatives, Sales Effectiveness, as well as, Managed Global Steering Committees, Advisory Boards, Congress Initiatives, Market Research, and Key Opinion Leaders

§ Facilitated Internal Client Workshop Teams on Lifecycle, Marketing, and In-Licensing Planning Activities for Cardiovascular, CNS, Pain, Women’s Health, and Specialty Device and Pharmaceutical Brands 2008-2010 Pharmaceutical Digital Agency New York City General Manager, Digital Communications Agency, SuperNova DIgital (company acquired) Led Executive Level Governance Teams and Restructure/Consolidate Business Operations

§ Strategic, Business Development, and Operational Accountability for NYC based privately held promotional medical advertising/communications agency, and managed staff of 35 with $13MM P/L

§ Oversight of Multi-Functional account managers, creative, editors, marketing, medical, project managers, technology, and writers

§ Developed New Company Positioning and Capabilities that resonated with unmet client needs

§ Mentored/Coached Teams on product profiles, patient journeys, value based capabilities presentations, redefined digital solutions 2007-2008 CNS Health Management Services Los Angeles Vice President, Marketing and Strategy, Hythiam Pharmaceuticals (company acquired) Strategic Planning, Marketing, Centers of Excellence, DTC, and KOL Management

§ Developed all Marketing Plans, Communications Strategies, and Organizational Competencies for multi-channel CNS Healthcare Services Management Company, providing pharmacological, nutritional, psychosocial addiction treatment and practice management services for Private Practitioners, Managed Care, Hospitals, and Centers of Excellence

§ Led Pricing Analysis, Managed Care Pull-Through Programs, Promotional Education/Value Proposition activities and extensive Key Opinion Leader, Med Ed Boards, and Relationship Management activities

§ Developed Customizable Practice Management Program resulting in significant improvements in Physician Productivity and Revenue

§ Developed DTC Medical, Nutritional, and Relapse Prevention Communication Strategies/Guidelines resulting in improved understanding of science, data, outcomes, and messaging

§ Managed 13 staff members, $9MM P/L, and exceeded product revenue growth projections 2005-2007 Global Healthcare Organization NJ

Director, New Product Commercialization, Johnson & Johnson Proven Methodologies for Defining the Process of Building Deep Customer/Market Insights

• Commercial leadership for existing compound development programs, including strategy, financial, PE Modeling, IP assessment, Pre-Market readiness (Value Proposition, Pull-Through Programs, Med Ed Initiatives, Branding/Naming, Market Research, Influence Mapping, Pricing Analysis)

• Pipeline Management for products ranging $100MM-2B+, including competitive analysis of marketed products and/or new compounds for in -licensing, co-promote, or 505B(2) opportunities

• Launched JnJ’s New Marketing and Business Planning Process “Marketing-Excellence” with Proven Methodologies for Defining Building Deep Customer/Market Insights and Comprehensive Marketing Approach to Sustainable HCP/Pt Behavioral Changes 2002-2005 US Pharmaceutical Organization NJ

Director, Cardiovascular Brand Management, Reliant (company acquired) Proven Methodologies for Defining the Process of Building Deep Customer/Market Insights

• Led Marketing and Specialty Sales Team activities for newly acquired brand of AFib Drugs

• Launched Rythmol CV brands including Pricing, MCO Programs, Specialty Sales Training, Promotional Materials, Med Ad Boards, National Launch Mtg, and Patient Assistance Program with P/L of $15MM

• Leveraged National and Regional KOL Relationships to Drive Utilization, Implement Center of Excellence, Create Phase IV Registry, Change Tx Guidelines, and Developed Interactive PE Model

• Exceptional Three-Year Sales Growth ($50MM, $96MM, $128MM) 1998-2002 Global Consulting Organization NYC

Director, Operations & Marketing Services, KPMG

Director for $500MM Line of Business

• Strategic Business Development, Communications, Client Servicing, Marketing, Staff Development, and Tactical Implementation for

$500MM Line of Businesses (Auto, Energy, Life Sciences, Transportation)

• Reported to Vice Chairman and led development of LoB Business Strategies, Marketing, Branding, Thought Leadership, and PR

• Delivered Integrated Industrial Markets Go-To-Market and Communication Strategies

• Oversight for Traditional Retention-Growth Client Management strategies within Key Accounts Resulting in 22% average growth 1996-1998 Global Bio-Pharmaceutical and Medical Device Organization NJ Director, Global Product Development, Johnson & Johnson Global Project Management for First to Market Coronary Stents & Delivery Systems

• Led global product development teams through strategic portfolio management and product development plans for Heparin Coated Stents, encompassing human resources, capital requirements, process improvements (design control and project management) and financial analysis for $30MM P/L program with projected 4 year sales of $300MM Education, Awards, Publications

Education

• Superior New Product Development; Harvard Business School

• Project Management Certification; Kepner Tregoe

• Combination Degree; MBA/MS Management Systems Analysis, Kean University

• B.S. BioMedical Engineering; Boston University (Academic Scholarship) Awards/Community Services

• Novartis Business Excellence Innovation Award for “First Ever” Marketing Delivery Catalog

• Cognizant Innovation Award for New Service Offerings

• Becton Dickenson Award for Outstanding Brand and Sales/Marketing Strategies

• Boston University Outstanding Community Services Award

• Founded 501c3 non-profit organization on Childhood Diseases

• Fifty Professional Recommendations on LinkedIn

Publications

• Virtual Brand Management; Portfolio Management

• Accelerating Bio-Pharma’s Marketing Transformation; Optimizing Promotional Content Process

• Global Audit; Ensuring Global Compliance

• Achieving IT Strategic Directives; How Business can Direct IT to Leverage Best Practices for Evaluating Enterprise-Wide Platforms

• PDF Rendering Factory Model; Reducing Spend on Process and Redirecting Funds to Drive Behavior

Contact this candidate